Haemonetics (HAE) Tops Q3 EPS by 10c; raises guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $77.29 -0.43%
Revenue Growth %: +2.3%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +2.3%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.04, $0.10 better than the analyst estimate of $0.94. Revenue for the quarter came in at $336 million versus the consensus estimate of $320.77 million.
GUIDANCE:
Haemonetics sees FY2024 EPS of $3.90-$4.00, versus the consensus of $3.89.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- UBS Downgrades Grand Korea Leisure (114090:KS) to Neutral
- Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
